4-168928326-TAAAA-TAAA

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBA1

The ENST00000507699.1(PALLD):​n.3748delA variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.67 ( 35550 hom., cov: 0)
Exomes 𝑓: 0.76 ( 8176 hom. )

Consequence

PALLD
ENST00000507699.1 non_coding_transcript_exon

Scores

Not classified

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 3.04

Publications

1 publications found
Variant links:
Genes affected
PALLD (HGNC:17068): (palladin, cytoskeletal associated protein) This gene encodes a cytoskeletal protein that is required for organizing the actin cytoskeleton. The protein is a component of actin-containing microfilaments, and it is involved in the control of cell shape, adhesion, and contraction. Polymorphisms in this gene are associated with a susceptibility to pancreatic cancer type 1, and also with a risk for myocardial infarction. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
CBR4 (HGNC:25891): (carbonyl reductase 4) Enables several functions, including 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity; NADPH binding activity; and NADPH dehydrogenase (quinone) activity. Involved in fatty acid biosynthetic process; glycoside metabolic process; and protein tetramerization. Located in mitochondrial matrix. Part of oxidoreductase complex. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP6
Variant 4-168928326-TA-T is Benign according to our data. Variant chr4-168928326-TA-T is described in ClinVar as Benign. ClinVar VariationId is 348072.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.932 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PALLDNM_001166108.2 linkc.*2156delA 3_prime_UTR_variant Exon 22 of 22 ENST00000505667.6 NP_001159580.1 Q8WX93-9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PALLDENST00000505667.6 linkc.*2156delA 3_prime_UTR_variant Exon 22 of 22 1 NM_001166108.2 ENSP00000425556.1 Q8WX93-9

Frequencies

GnomAD3 genomes
AF:
0.669
AC:
101266
AN:
151282
Hom.:
35539
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.439
Gnomad AMI
AF:
0.812
Gnomad AMR
AF:
0.703
Gnomad ASJ
AF:
0.694
Gnomad EAS
AF:
0.954
Gnomad SAS
AF:
0.787
Gnomad FIN
AF:
0.803
Gnomad MID
AF:
0.737
Gnomad NFE
AF:
0.746
Gnomad OTH
AF:
0.683
GnomAD4 exome
AF:
0.760
AC:
21290
AN:
27996
Hom.:
8176
Cov.:
0
AF XY:
0.766
AC XY:
9837
AN XY:
12844
show subpopulations
African (AFR)
AF:
0.465
AC:
443
AN:
952
American (AMR)
AF:
0.726
AC:
446
AN:
614
Ashkenazi Jewish (ASJ)
AF:
0.703
AC:
1248
AN:
1776
East Asian (EAS)
AF:
0.942
AC:
5192
AN:
5512
South Asian (SAS)
AF:
0.781
AC:
175
AN:
224
European-Finnish (FIN)
AF:
0.794
AC:
351
AN:
442
Middle Eastern (MID)
AF:
0.709
AC:
122
AN:
172
European-Non Finnish (NFE)
AF:
0.733
AC:
11730
AN:
16012
Other (OTH)
AF:
0.691
AC:
1583
AN:
2292
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.517
Heterozygous variant carriers
0
233
466
698
931
1164
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
68
136
204
272
340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.669
AC:
101316
AN:
151396
Hom.:
35550
Cov.:
0
AF XY:
0.676
AC XY:
50011
AN XY:
73982
show subpopulations
African (AFR)
AF:
0.438
AC:
17990
AN:
41048
American (AMR)
AF:
0.704
AC:
10712
AN:
15224
Ashkenazi Jewish (ASJ)
AF:
0.694
AC:
2407
AN:
3470
East Asian (EAS)
AF:
0.954
AC:
4917
AN:
5152
South Asian (SAS)
AF:
0.788
AC:
3790
AN:
4810
European-Finnish (FIN)
AF:
0.803
AC:
8407
AN:
10472
Middle Eastern (MID)
AF:
0.755
AC:
222
AN:
294
European-Non Finnish (NFE)
AF:
0.746
AC:
50688
AN:
67912
Other (OTH)
AF:
0.686
AC:
1444
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
1542
3084
4625
6167
7709
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
804
1608
2412
3216
4020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.660
Hom.:
1399

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Carcinoma of pancreas Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
3.0
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs398064261; hg19: chr4-169849477; COSMIC: COSV54971964; COSMIC: COSV54971964; API